PIK3CA and breast cancer: Most of the somatic mutations identified were private to one of the metastatic deposits and the likely pathogenic hotspot PIK3CA K111T mutation, a recurrently mutated residue in breast cancer [16], was private to and clonal in the brain metastasis #2 (BM2).